Clinical Trials for Galimedix Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Galimedix Therapeutics

Clinical Trials (1)

NCT06659549
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
PHASE2Recruiting
110 participants
Started: Jan 10, 2025 · Completed: May 30, 2027
1 condition2 sponsors12 locations